FDA committee votes against ADHD "black box"

An FDA advisory committee has voted against requiring a "black box" warning for ADHD drugs. Instead of getting a tougher warning, the experts recommend that the drugs come with labels that are clearer and easier for people to understand. A separate FDA panel had recommended a black box warning due to the cardiovascular risks associated with the therapies. ADHD drugs are stimulants, which raise blood pressure and increase the risk of heart attacks. A number of psychiatrists had warned against the agency's toughest label, noting that the therapies are badly needed for effective treatment. Children with heart problems, they said, should be identified and not provided the meds.

- read this article [1] from the Los Angeles Times for more information